[HTML][HTML] Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns

J Schouten, J De Waele, C Lanckohr, D Koulenti… - International Journal of …, 2021 - Elsevier
Since the start of the COVID-19 pandemic, there has been concern about the concomitant
rise of antimicrobial resistance (AMR). While bacterial co-infections seem rare in COVID-19 …

[HTML][HTML] Challenges to antimicrobial stewardship in the countries of the Arab League: Concerns of worsening resistance during the COVID-19 pandemic and proposed …

NA Rizk, R Moghnieh, N Haddad, MC Rebeiz… - Antibiotics, 2021 - mdpi.com
The COVID-19 pandemic is expected to worsen the global problem of antimicrobial
resistance (AMR). There is a heightened interest in understanding this effect and to develop …

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis

A Alami, D Krewski, N Farhat, D Mattison, K Wilson… - BMJ open, 2023 - bmjopen.bmj.com
Objective To summarise the available evidence on the risk of myocarditis and/or pericarditis
following mRNA COVID-19 vaccination, compared with the risk among unvaccinated …

[HTML][HTML] Foodborne and Animal Contact Disease Outbreaks: HIV in Canada—surveillance report, 2019

N Haddad, A Weeks, A Robert… - Canada communicable …, 2021 - ncbi.nlm.nih.gov
Background Human immunodeficiency virus (HIV) is a global public health issue. HIV has
been nationally notifiable in Canada since 1985. The Public Health Agency of Canada …

[HTML][HTML] The Impact of Antimicrobial Stewardship and Infection Control Interventions on Acinetobacter baumannii Resistance Rates in the ICU of a Tertiary Care …

NA Rizk, N Zahreddine, N Haddad, R Ahmadieh… - Antibiotics, 2022 - mdpi.com
Antimicrobial resistance is a serious threat to global health, causing increased mortality and
morbidity especially among critically ill patients. This toll is expected to rise following the …

Public health measures to reduce the risk of SARS-CoV-2 transmission in Canada during the early days of the COVID-19 pandemic: a scoping review

J Polisena, M Ospina, O Sanni, B Matenchuk… - BMJ open, 2021 - bmjopen.bmj.com
Objective The main objectives of this study were to synthesise and compare pandemic
preparedness strategies issued by the federal and provincial/territorial (P/T) governments in …

[HTML][HTML] Myocarditis and pericarditis post-mRNA covid-19 vaccination: insights from a pharmacovigilance perspective

A Alami, PJ Villeneuve, PJ Farrell, D Mattison… - Journal of Clinical …, 2023 - mdpi.com
Concerns remain regarding the rare cardiovascular adverse events, myocarditis and
pericarditis (myo/pericarditis), particularly in younger individuals following mRNA COVID-19 …

Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents

N Farhat, Y Fortin, N Haddad, N Birkett… - Critical Reviews in …, 2019 - Taylor & Francis
The potential association between major adverse cardiovascular events (MACE) and
concomitant treatment with proton pump inhibitors (PPIs) and clopidogrel has been debated …

[HTML][HTML] Evaluation of carbapenem use before and after implementation of an antimicrobial stewardship-led carbapenem-sparing strategy in a Lebanese tertiary …

M El Masri, N Haddad, T Saad, NA Rizk… - Frontiers in cellular …, 2022 - frontiersin.org
Purpose The use of carbapenem before and after implementation of an antimicrobial
stewardship-led carbapenem-sparing strategy at a tertiary care center in Lebanon was …

Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000–2016

N Farhat, N Haddad, J Crispo, N Birkett… - European Journal of …, 2019 - Springer
Abstract Purpose The US Food and Drug Administration (FDA) issued three safety
announcements between January 2009 and October 2010 warning against concomitant use …